Pressroom: Media Coverage

Showing 481 - 500 of 598 news items

2011

Study Weakens Case for Preventive Mastectomy

Medical oncologist Mark Robson comments to the Wall Street Journal on findings published in the Journal of Clinical Oncology reporting that women with mothers and sisters who carry one of the BRCA gene mutations but who aren't carriers themselves don't have an especially heightened risk of breast cancer. Robson and medical oncologist Andrew Seidman were also quoted in MedPage Today, with Seidman expressing hope that the findings would cut down on "unwarranted and excessive screening and/or risk-reducing interventions."

November 1, 2011
One Father's Special Reason to Run

Pediatric neurologist Kevin De Braganca was interviewed about his patient, Ty Campbell, whose father and aunt are running the NYC marathon for Fred's Team.

October 28, 2011
From Unknown Cancer Gene to Potential Cancer Drug

Cancer biology and genetics research fellow Elisa Oricchio has identified a gene – EPHA7 – whose loss can lead to a sluggish but hard-to-treat type of lymphoma called follicular lymphoma.

October 27, 2011
Creator of Patient Navigators to Help the Disadvantaged Visits St. Louis

The Breast Examination Center of Harlem’s Harold Freeman pioneered the system of personal care and service provided by patient navigators to prevent sick people and poor people from falling through the cracks in healthcare delivery.

October 27, 2011
Monoclonal Gammopathy of Undetermined Significance (MGUS): Questions About Symptoms, Related Diseases

Hematologist-oncologist Hani Hassoun answers questions about MGUS, a blood disorder that can be a precursor to the cancer, multiple myeloma.

October 27, 2011
Is This the End of Popping Vitamins?

Hematologist-oncologist Mark Heaney discusses recent studies that suggest multivitamins and many other dietary supplements often don’t have health benefits — and in some cases may even cause harm.

October 25, 2011
'It's Surprisingly Liberating Not To Have Hair'

Seventeen-year-old Ella Landesberg has been chronicling the ups and downs of her experience battling acute lymphoblastic leukemia on her blog. Pediatric hematologist-oncologist Peter Steinherz explains the disease.

October 25, 2011
Mammogram's Role as Savior Is Tested

Epidemiologist Colin Begg discusses a new analysis published in the Archives of Internal Medicine that offers a stark reality check about the value of mammography screening.

October 24, 2011
Copper-Coated Era Beckons for Hospitals

As part of a national study on the effectiveness of copper as an antimicrobial surface, Memorial Sloan Kettering was one of several U.S. hospitals to temporarily install copper-coated equipment surfaces in some intensive care units. Investigator and infectious disease specialist Kent Sepkowitz is quoted.

October 21, 2011
Femara May Beat Tamoxifen at Preventing Breast Cancer's Return

Medical oncologist Maura Dickler discusses new research that found that the breast cancer drug letrozole, marketed as Femara, may be more effective than tamoxifen at preventing the return of breast cancer and improving survival among older women with hormone-sensitive breast cancers.

October 21, 2011
Radiation Plus Surgery Cuts Risk of Breast Cancer Return

Medical oncologist Elizabeth Comen discusses new research that shows that adding radiation therapy to breast-conserving surgery halves the chance that cancer will come back and reduces the risk of dying from breast cancer, when compared to the breast-conserving surgery alone.

October 20, 2011
Latest on Breast Cancer Research with Larry Norton on ABC's "The View"

Watch medical oncologist Larry Norton speaking about the latest in breast cancer research on ABC's The View. Norton is Memorial Sloan Kettering's Deputy Physician-in-Chief for Breast Cancer Programs as well as the Medical Director of the Evelyn H. Lauder Breast Center.

October 19, 2011
Arms Wide Open Childhood Cancer Foundation Give Thanks for Life Gala

The neuroblastoma team at Memorial Sloan Kettering was honored with a $125,000 grant from Arms Wide Open Childhood Cancer Foundation. Awards of Excellence went to pediatric surgeon Michael La Quaglia and nurse practitioner Ester Dantis.

October 18, 2011
Stacey Sager's Life Saved with Help of Genetic Test

Eyewitness News reporter and cancer survivor Stacey Sager discusses genetic testing for the mutation that causes breast and ovarian cancer. Medical oncologist and geneticist Kenneth Offit, gynecologic oncologist Carol Aghajanian, and gynecologic surgeon Richard Barakat were all interviewed for the special.

October 14, 2011
Vitamin E Is Linked to Prostate Cancer

Memorial Sloan Kettering epidemiologist Andrew Vickers discusses new research that found that vitamin E supplements may increase the risk of prostate cancer.

October 12, 2011
Urban Sanctuary: Brooklyn Infusion Center in New York, Designed by ZGF Architects

Memorial Sloan Kettering’s Brooklyn Infusion Center is profiled in this piece. "Patients own this facility and design their own experience," said Wendy Perchick, MSKCC's Chief of Strategic Planning and Innovation, adding: "The best testament to the success of this new model for cancer treatment? A patient told me that he felt the healing intensified here because he was so relaxed."

October 12, 2011
The Search for a Breast Cancer Cure

Medical oncologist Carolyn Wasserheit and Medical Director of the Regional Care Network Maureen Killackey discuss the latest breast cancer research.

October 12, 2011
Cancer Patients Could Benefit From Greater Use of Rehabilitation

Memorial Sloan Kettering is one of only two hospitals to offer advanced medical fellowships to physicians who want to specialize in cancer rehabilitation. Chief of MSKCC’s Rehabilitation Medicine Service Michael Stubblefield is mentioned.

October 10, 2011
Music Therapy Hitting Right Notes For Patients

Memorial Sloan Kettering music therapist Karen Popkin discusses the benefits of music therapy among cancer patients in this video interview.

October 10, 2011
Two-Drug Combo May Help Hard-to-Treat Leukemia

Memorial Sloan Kettering medical oncologist Nicole Lamanna discusses new research that shows clear benefits of the combination of Campath and Fludara for relapsed refractory cases of Chronic Lymphocytic Leukemia (CLL).

October 10, 2011